Jove
Visualize
Contact Us

Related Concept Videos

Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

197
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
197
Methods for Studying Drug Absorption: In vitro01:16

Methods for Studying Drug Absorption: In vitro

536
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
536
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

198
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
198
Bioavailability: Overview01:13

Bioavailability: Overview

3.9K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
3.9K
Bioavailability: Overview01:17

Bioavailability: Overview

298
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
298
Methods for Studying Drug Absorption: In situ01:09

Methods for Studying Drug Absorption: In situ

588
In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
588

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From scientist to successful drug hunter - a mindset shift.

Drug discovery today·2026
Same author

Unphysical Structure Collapse in Quantum Mechanics Calculations With Continuum Solvation.

Chemphyschem : a European journal of chemical physics and physical chemistry·2026
Same author

CACHE Challenge #3: Targeting the Nsp3 Macrodomain of SARS-CoV-2.

Journal of chemical information and modeling·2026
Same author

Rationale and Design of the HeartShare/AMP-HF Deep Phenotyping Study to Improve Understanding of Heart Failure With Preserved Ejection Fraction.

JACC. Heart failure·2025
Same author

Polycystic ovary syndrome and elevated body mass index independently increase type 2 diabetes risk with obesity-mediated risk dominating: a real-world data analysis of US patients.

Fertility and sterility·2025
Same author

CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13.

Journal of chemical information and modeling·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 4, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.5K

Prediction of Oral Bioavailability in Rats: Transferring Insights from in Vitro Correlations to (Deep) Machine

Sebastian Schneckener1, Sergio Grimbs1, Jessica Hey1

  • 1Bayer AG, Engineering & Technology, Applied Mathematics , 51368 Leverkusen , Germany.

Journal of Chemical Information and Modeling
|November 13, 2019
PubMed
Summary

Predicting oral drug bioavailability is crucial for drug discovery. This study shows in vitro data better predicts oral drug exposure in rats than in silico models, achieving a fold change error of 2.40.

More Related Videos

Use of a High-throughput In Vitro Microfluidic System to Develop Oral Multi-species Biofilms
07:09

Use of a High-throughput In Vitro Microfluidic System to Develop Oral Multi-species Biofilms

Published on: December 1, 2014

13.9K
Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug
08:28

Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug

Published on: December 14, 2021

9.9K

Related Experiment Videos

Last Updated: Jan 4, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.5K
Use of a High-throughput In Vitro Microfluidic System to Develop Oral Multi-species Biofilms
07:09

Use of a High-throughput In Vitro Microfluidic System to Develop Oral Multi-species Biofilms

Published on: December 1, 2014

13.9K
Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug
08:28

Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug

Published on: December 14, 2021

9.9K

Area of Science:

  • Pharmacokinetics and Drug Metabolism
  • Computational Chemistry and Cheminformatics

Background:

  • Oral drug administration is a primary route, necessitating accurate bioavailability prediction for drug discovery candidate prioritization.
  • Predicting oral exposure is complex, influenced by physicochemical properties and organism interactions like metabolism and membrane permeation.

Purpose of the Study:

  • To evaluate the predictability of intravenous (IV) and oral drug exposure and oral bioavailability in rats.
  • To compare the efficacy of in vitro, in silico, and chemical structure-based models for predicting drug exposure.

Main Methods:

  • Utilized a dataset of nearly 1900 in vivo rat experiments.
  • Employed six experimentally determined in vitro/physicochemical endpoints (membrane permeation, free fraction, metabolic stability, solubility, pKa, lipophilicity).
  • Incorporated outputs from six in silico absorption, distribution, metabolism, and excretion (ADME) models and chemical structure representations (fingerprints, SMILES).

Main Results:

  • Intravenous (IV) drug exposure prediction accuracy was comparable using in vitro or in silico inputs (FCE 2.28 vs. 2.08).
  • Oral drug exposure prediction showed higher fold change errors (FCEs), with in vitro inputs (FCE 3.49) outperforming in silico models (FCE 2.40).
  • A simplified binary prediction for low oral bioavailability using only chemical structure achieved ~70% accuracy and precision.

Conclusions:

  • In vitro data provides more reliable predictions for oral drug exposure compared to in silico models, likely due to the complexity of oral bioavailability.
  • Hybrid models combining in vitro or in silico data can effectively predict IV drug exposure.
  • Chemical structure alone offers a useful, albeit limited, tool for initial screening of low oral bioavailability potential.